MCT Beginning

1. The evaluation of the overall residual risk takes into account, among other things:

• The sum of individual risks
• The sequence of events
• Special harm
• Risk control measures in conflict with other requirements
• Too many warnings

2. The quantitative risk assessment appeared over the years:

• 1650
• 1792
• 2004
• 2009

3. The requirements of ISO 14971 version 2019 are:

• 134
• 309
• 416

4. To evaluate the risks related to the saety of the medical device after the start of marketing:

• A risk management plan is used
• A production information collection system is used
• A system for collecting post-production information is used
• A production information review system is used
• A post-production information review system is used
• A post-market monitoring plan is used

5. Following the risk evaluation we can:

• Analyze the risk
• Judge the risk acceptable
• Keep control measures as they are
• Improve existing control measures